- Home
- CGEN vs BSET Comparison
CGEN vs BSET Comparison
Compare CGEN & BSET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CGEN | BSET |
|---|---|---|
| Founded | 1993 | 1902 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.3M | 132.4M |
| IPO Year | 2000 | 1987 |
Fundamental Metrics
Financial Performance| Metric | CGEN | BSET |
|---|---|---|
| Price | $1.65 | $15.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 271.2K | 21.7K |
| Earning Date | 11-10-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 5.17% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.90 |
| Revenue | $6,903,000.00 | ★ $330,953,000.00 |
| Revenue This Year | N/A | $3.11 |
| Revenue Next Year | $231.15 | $3.00 |
| P/E Ratio | ★ N/A | $17.28 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.13 | $13.58 |
| 52 Week High | $2.66 | $19.75 |
Technical Indicators
Market Signals| Indicator | CGEN | BSET |
|---|---|---|
| Relative Strength Index (RSI) | 53.50 | 54.10 |
| Support Level | $1.47 | $15.30 |
| Resistance Level | $1.61 | $16.02 |
| Average True Range (ATR) | 0.09 | 0.46 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 72.03 | 65.68 |
Price Performance
Historical ComparisonAbout CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.